Lekhraj Patel, MD | |
3848 Fau Blvd Ste 305, Boca Raton, FL 33431-6437 | |
(305) 243-3100 | |
(561) 393-7312 |
Full Name | Lekhraj Patel |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 37 Years |
Location | 3848 Fau Blvd Ste 305, Boca Raton, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891752952 | NPI | - | NPPES |
51469 | Other | FL | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | C128200 (California) | Secondary |
2084N0400X | Psychiatry & Neurology - Neurology | ME82377 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Orlando Health | Orlando, FL | Hospital |
Physicians Regional Medical Center - Pine Ridge | Naples, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Access Telecare Pllc | 7810204831 | 262 |
Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
A recent article in the prestigious British Medical Journal seems to confirm an increased risk for suicidal behavior among adults taking popular antidepressants. This follows evidence that certain selective serotonin reuptake inhibitors (SSRIs) may have a similar effect among children and adolescents.
In addition to a person's race or ethnicity, where they live can matter in terms of whether they are diagnosed at a late stage for colorectal cancer, according to a recent study led by a researcher at the School of Public Health at Georgia State University.
Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital in Toronto.
Ansell, a global leader in protection solutions today announced it will introduce SANDEL healthcare safety devices in EMEA this year, with Australia, New Zealand and South America to follow thereafter. SANDEL will be first introduced during the 6th Annual EORNA (European Operating Room Nurses Association) Congress held from April 26 to 29 in Lisbon, Portugal.
› Verified 8 days ago
Entity Name | Orlando Health Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
A recent article in the prestigious British Medical Journal seems to confirm an increased risk for suicidal behavior among adults taking popular antidepressants. This follows evidence that certain selective serotonin reuptake inhibitors (SSRIs) may have a similar effect among children and adolescents.
In addition to a person's race or ethnicity, where they live can matter in terms of whether they are diagnosed at a late stage for colorectal cancer, according to a recent study led by a researcher at the School of Public Health at Georgia State University.
Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital in Toronto.
Ansell, a global leader in protection solutions today announced it will introduce SANDEL healthcare safety devices in EMEA this year, with Australia, New Zealand and South America to follow thereafter. SANDEL will be first introduced during the 6th Annual EORNA (European Operating Room Nurses Association) Congress held from April 26 to 29 in Lisbon, Portugal.
› Verified 8 days ago
Entity Name | Access Telecare Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013303080 PECOS PAC ID: 7810204831 Enrollment ID: O20191014003264 |
News Archive
A recent article in the prestigious British Medical Journal seems to confirm an increased risk for suicidal behavior among adults taking popular antidepressants. This follows evidence that certain selective serotonin reuptake inhibitors (SSRIs) may have a similar effect among children and adolescents.
In addition to a person's race or ethnicity, where they live can matter in terms of whether they are diagnosed at a late stage for colorectal cancer, according to a recent study led by a researcher at the School of Public Health at Georgia State University.
Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital in Toronto.
Ansell, a global leader in protection solutions today announced it will introduce SANDEL healthcare safety devices in EMEA this year, with Australia, New Zealand and South America to follow thereafter. SANDEL will be first introduced during the 6th Annual EORNA (European Operating Room Nurses Association) Congress held from April 26 to 29 in Lisbon, Portugal.
› Verified 8 days ago
Entity Name | University Of Miami |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
A recent article in the prestigious British Medical Journal seems to confirm an increased risk for suicidal behavior among adults taking popular antidepressants. This follows evidence that certain selective serotonin reuptake inhibitors (SSRIs) may have a similar effect among children and adolescents.
In addition to a person's race or ethnicity, where they live can matter in terms of whether they are diagnosed at a late stage for colorectal cancer, according to a recent study led by a researcher at the School of Public Health at Georgia State University.
Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital in Toronto.
Ansell, a global leader in protection solutions today announced it will introduce SANDEL healthcare safety devices in EMEA this year, with Australia, New Zealand and South America to follow thereafter. SANDEL will be first introduced during the 6th Annual EORNA (European Operating Room Nurses Association) Congress held from April 26 to 29 in Lisbon, Portugal.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Lekhraj Patel, MD 233 S Federal Hwy, Ste 110, Boca Raton, FL 33432-4937 Ph: (561) 750-7955 | Lekhraj Patel, MD 3848 Fau Blvd Ste 305, Boca Raton, FL 33431-6437 Ph: (305) 243-3100 |
News Archive
A recent article in the prestigious British Medical Journal seems to confirm an increased risk for suicidal behavior among adults taking popular antidepressants. This follows evidence that certain selective serotonin reuptake inhibitors (SSRIs) may have a similar effect among children and adolescents.
In addition to a person's race or ethnicity, where they live can matter in terms of whether they are diagnosed at a late stage for colorectal cancer, according to a recent study led by a researcher at the School of Public Health at Georgia State University.
Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital in Toronto.
Ansell, a global leader in protection solutions today announced it will introduce SANDEL healthcare safety devices in EMEA this year, with Australia, New Zealand and South America to follow thereafter. SANDEL will be first introduced during the 6th Annual EORNA (European Operating Room Nurses Association) Congress held from April 26 to 29 in Lisbon, Portugal.
› Verified 8 days ago
Lourdes J Chahin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7789 Nw Beacon Square Blvd, Boca Raton, FL 33487 Phone: 561-241-7977 Fax: 561-981-5355 | |
Dr. Stuart H Isaacson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 951 Nw 13th St, Bldg 5-e, Boca Raton, FL 33486 Phone: 561-392-1818 Fax: 561-392-8989 | |
Dr. Yefim Cavalier, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9970 Central Park Blvd N Ste 207, Boca Raton, FL 33428 Phone: 561-482-1027 | |
Dr. Roger Z Samuel, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 7100 Camino Real Ste 401, Boca Raton, FL 33433 Phone: 561-368-8998 Fax: 561-392-9170 | |
Dr. Renata Chalfin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7000 W Palmetto Park Rd Ste 406, Boca Raton, FL 33433 Phone: 561-961-8575 Fax: 561-898-1710 | |
Dr. Jessica Evelson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5550 Glades Rd Ste 305-16, Boca Raton, FL 33431 Phone: 561-668-4525 Fax: 561-437-8263 | |
Dargelis Chi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9970 Central Park Blvd N Ste 207, Boca Raton, FL 33428 Phone: 561-482-1027 Fax: 614-882-1028 |